Estrella Immunopharma, Inc.
ESLAW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001844417
No open-market purchases or sales by Estrella Immunopharma, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $249.2K in total; no superinvestor holds it.
Other share classesESLA
13F holders, Q1 2025
Institutional positions in Estrella Immunopharma, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- −1 vs. Q4 2024
- Shares held
- 731.4K
- −29.2K (−3.8%) vs. Q4 2024
- Total value
- $86.1K
- +$7.86K (+10.0%) vs. Q4 2024
- New holders
- 1
- 1 more added
- Sold out
- 2
- 1 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ESLAW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $249.2K |
| Q1 2026 | 8 | $235.9K |
| Q4 2025 | 9 | $354.1K |
| Q3 2025 | 12 | $26.9K |
| Q2 2025 | 12 | $26.2K |
| Q1 2025 | 11 | $86.1K |
| Q4 2024 | 12 | $78.3K |
| Q3 2024 | 14 | $75.4K |
| Q2 2024 | 15 | $44.9K |
| Q1 2024 | 14 | $56.3K |
| Q4 2023 | 14 | $27.9K |
| Q3 2023 | 1 | $1.75K |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Estrella Immunopharma, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 4,453 | $343 | 0.00% | +4,453 | New |
| Landscape Capital Management, L.L.C. | 13,682 | $1.05K | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 28,691 | $2.21K | 0.00% | +100+0.3% | Added |
| Whitebox Advisors LLC | 42,293 | $3.26K | 0.00% | 00.0% | Unchanged |
| Yakira Capital Management, Inc. | 46,485 | $4.11K | 0.00% | 00.0% | Unchanged |
| Walleye Trading LLC | 72,834 | $5.61K | 0.00% | −20,136−21.7% | Reduced |
| SkyView Investment Advisors, LLC | 62,500 | $6.00K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 87,500 | $6.74K | 0.00% | 00.0% | Unchanged |
| Atw Spac Management LLC | 183,099 | $16.2K | 0.03% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | – | $40.6K | 0.00% | – | – |
| Boothbay Fund Management, LLC | 189,899 | – | – | 00.0% | Unchanged |
| Walleye Capital LLC | 0 | $0 | 0.00% | −10,330−100.0% | Sold out |
| Wolverine Asset Management LLC | 0 | $0 | 0.00% | −3,256−100.0% | Sold out |